Press Releases | BioSenic

Bone Therapeutics Notice of Full Year 2016 Results

Read more about Bone Therapeutics Notice of Full Year 2016 Results

Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer

Read more about Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer

Bone Therapeutics completes recruitment of 16 patients in ALLOB Phase I/IIA delayed-union study

Read more about Bone Therapeutics completes recruitment of 16 patients in ALLOB Phase I/IIA delayed-union study

Bone Therapeutics to participate in upcoming key investor conferences

Read more about Bone Therapeutics to participate in upcoming key investor conferences

Bone Therapeutics Reports Full Year 2016 Results

Read more about Bone Therapeutics Reports Full Year 2016 Results

Bone Therapeutics announces the publication of its Annual Report 2016

Read more about Bone Therapeutics announces the publication of its Annual Report 2016

Bone Therapeutics: The preliminary documents for the Annual General Shareholder Meeting on 26 May 2017 have been made available

Read more about Bone Therapeutics: The preliminary documents for the Annual General Shareholder Meeting on 26 May 2017 have been made available

Bone Therapeutics Business Update for First Quarter 2017

Read more about Bone Therapeutics Business Update for First Quarter 2017

Bone Therapeutics strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors

Read more about Bone Therapeutics strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors

Bone Therapeutics completes patient recruitment for pivotal interim analysis of Phase III Osteonecrosis trial with PREOB

Read more about Bone Therapeutics completes patient recruitment for pivotal interim analysis of Phase III Osteonecrosis trial with PREOB

Subscribe to Press Releases